Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 58 Carcinoma, Non-Small-Cell Lung 53 Breast Neoplasms 19 Pancreatic Neoplasms 11 Small Cell Lung Carcinoma 9 Ovarian Neoplasms 9 Melanoma 9 Colorectal Neoplasms 8 Colonic Neoplasms 8 Stomach Neoplasms 7 Sarcoma 7 Head and Neck Neoplasms 7 Neoplasms 6 Pleural Effusion, Malignant 5 Mesothelioma 5 Carcinoma, Renal Cell 5 Urinary Bladder Neoplasms 4 Adenocarcinoma of Lung 4 Uterine Cervical Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Prostatic Neoplasms 3 Osteosarcoma 3 Neoplasm Metastasis 3 Glioblastoma 3 Esophageal Neoplasms 3 Carcinoma, Hepatocellular 3 Brain Neoplasms 3 Rectal Neoplasms 2 Pulmonary Disease, Chronic Obstructive 2 NSCLC 2

Interventions

4-((5-chloro-2-pyridinyl)oxy)-1-((((4S)-4-methyl-2,5-dioxo-4-imidazolidinyl)methyl)sulfonyl)-piperidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Fibrosis × Thoracic × Clear all

NCT02604862 2020-02-13

FIB ONE

University of Edinburgh

Phase EARLY_PHASE1 Completed

Fibrosis, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡